{"id":"W4385302690","doi":"10.1038/s41591-023-02452-y","title":"Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Mesothelin; Medicine; Internal medicine; Pneumonitis; Interim analysis; Pembrolizumab; Oncology; Cytokine release syndrome; Clinical endpoint; Refractory (planetary science); Gastroenterology; Cancer; Clinical trial; Chimeric antigen receptor; Immunotherapy; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003520397,0.0004735131,0.001126295,0.001079773,0.0001155886,0.00002204546,0.0003930285,0.0007188503,0.005469274],"category_scores_gemma":[0.001838101,0.0003428407,0.0001952398,0.001663907,0.000356428,0.000100409,0.0001245466,0.00323373,0.0002247739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003127841,"about_ca_system_score_gemma":0.0003986323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001044073,"about_ca_topic_score_gemma":0.00001081153,"domain_scores_codex":[0.9951546,0.000422499,0.001256898,0.0008810069,0.001409778,0.0008752572],"domain_scores_gemma":[0.997196,0.0009267135,0.0003499006,0.000793256,0.0003246151,0.000409513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1038933,0.0005986702,0.00008457026,0.0001543393,0.0000316541,0.000412885,0.002286837,0.000001211269,0.8168789,0.000003325013,0.04560823,0.03004612],"study_design_scores_gemma":[0.268738,0.01006243,0.00007979225,0.0008775994,0.00003293024,0.00002908156,0.002478712,0.0002955698,0.4483346,0.00004463821,0.2686605,0.0003661381],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9668726,0.004352105,0.000005701363,0.005429965,0.002415131,0.002132624,0.00006029921,0.0003066289,0.01842499],"genre_scores_gemma":[0.9734553,0.005977402,0.0002167249,0.001437565,0.004512106,0.00006597939,0.0007772712,0.0001341163,0.01342352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3685442,"threshold_uncertainty_score":0.9999024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03486724585317036,"score_gpt":0.3866904057862175,"score_spread":0.3518231599330471,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}